CROSS-REFERENCE TERMINAL ... SEE ALSO
  RECORD ................. /pharma-transparency-guidelines-study-329
  STATUS ................. ACTIVE
  CROSS-REFERENCES ....... 1 (1 OUT / 0 IN)
  NAVIGATION ............. CLICK A CARD TO WALK THE ARCHIVE

Pharmaceutical Industry Transparency Guidelines Post-Study 329 Scrutiny

◂ RECORDS ROOMPULL THE FULL ANNOTATION →
Study 329: Paroxetine Clinical Trial Data Suppression and Publication Bias — SHARES-EVENT (OUTGOING)STUDY 329: PAROXETINE CLI…Pharmaceutical Industry Transparency Guidelines Post-Study 329 ScrutinyPHARMACEUTICAL INDUSTRY TRA…THIS FILESHARES-EVENT

REGISTER